3.4.21.27	A7r5 cell	-	752439	
3.4.21.27	blood	-	36530, 36531, 36532, 707856, 718045, 731538	
3.4.21.27	blood plasma	-	652338, 669347, 669428, 693547, 695184, 707856, 709721, 709722, 710438, 710600, 717420, 717844, 718042, 753068	
3.4.21.27	blood plasma	from patients with aortic stenosis	717416	
3.4.21.27	blood platelet	-	691466, 753068	
3.4.21.27	blood vessel	-	752615	
3.4.21.27	brain	-	36541	
3.4.21.27	commercial preparation	-	683682	
3.4.21.27	commercial preparation	from plasma	683160, 683167	
3.4.21.27	kidney	-	709722	
3.4.21.27	leukocyte	-	717958	
3.4.21.27	liver	-	707308, 709722	
3.4.21.27	additional information	hemophilia C (deficiency in FXI) is present in both sexes	707308	
3.4.21.27	additional information	the enzyme binds to platelets, a conformational transition accompanies conversion of factor XI to factor XIa that conceals the Apple 3 domain zymogen factor XI platelet binding site and exposes the factor XIa platelet binding site within the catalytic domain possibly comprising residues Cys527-Cys542, overview	683160	
3.4.21.27	pancreas	-	709722	
3.4.21.27	plasma	-	683157, 683160, 683167, 683682, 683756, 684078, 691011	
3.4.21.27	umbilical vein endothelial cell line	-	652309	
3.4.21.27	vascular smooth muscle cell	-	752439